Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

GENEREX BIOTECHNOLOGY CORP (GNBT)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsApr-30-21Jan-31-21Oct-31-20Jul-31-20Apr-30-20Jan-31-20Oct-31-19Jul-31-19
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
CASH FLOWS FROM OPERATING ACTIVITIES          
Net (Loss) Income  -38.8-53.0-35.9-34.2-27.6-33.0-38.1-11.0
   
Adjustments to reconcile net (loss) income to net cash used in operating activities:          
    Depreciation and amortization  1.00.90.90.80.50.50.60.4
    Amortization of operating lease right-of-use assets  0.20.20.20.20.10.00.0 
    Stock compensation expense  2.62.62.52.13.14.23.73.0
    Shares issued for services   0.1 0.30.3-0.7  
    Loss of disposal of fixed assets    0.20.20.2   
    Amortization of debt discount  1.61.82.54.45.86.15.23.1
    Change in fair value of derivative liabilities - convertible notes  -0.70.6-0.1-1.0-0.6-1.2-0.7 
    Change in fair value of derivative liabilities - downside protection      1.71.9-0.1-3.1
    Bad debt expense        0.0 
    Increase in notes payable due to default    0.80.50.1   
    Change in fair value of common stock payable  -0.10.1-0.10.00.0-0.1  
    Changes in operating assets and liabilities, net of effect of acquisitions:          
        Accounts receivable  0.10.10.00.0-1.4-1.5-0.7-0.8
        Inventory  0.70.20.0-0.1-0.40.50.81.1
        Accounts payable and accrued expenses  20.920.816.79.58.09.49.98.6
        Operating lease liabilities  -0.2-0.2 -0.2-0.10.0  
        Other current assets  0.10.20.10.0-0.3-0.1-0.1 
        Other assets     0.00.00.0 0.0
            Net cash used in operating activities  -2.4-3.8-5.6-6.1-7.0-10.2-11.1-9.6
   
CASH FLOWS FROM INVESTING ACTIVITIES:          
    Purchase of property and equipment       -0.3-0.3-0.3
    Cash received in acquisition of a business, net of cash paid        0.0 
        Net cash provided by investing activities       0.71.32.3
   
CASH FLOWS FROM FINANCING ACTIVITIES          
Loan (repayments to) and proceeds from related party  0.0   0.0   
Payment of notes payable  -2.3-0.1-0.1   -1.0-0.1
Proceeds from note payable  2.3  6.66.88.28.86.3
Proceeds from issuance of common stock  3.73.02.3  0.1  
Issuance of common stock in a private placement (PIPE), net of fees  3.73.02.3  0.1  
Proceeds from exercise of warrants  0.0 0.0     
    Net cash provided by financing activities  3.64.25.95.85.97.47.96.5
Cash and cash equivalents, beginning of period    0.0   0.3 
Cash and cash equivalents, end of period  1.30.30.30.0-0.7-1.8-1.50.3
   
Supplemental Disclosure of Cash Flow Information          
Cash paid for interest    0.1   0.0 
   
Supplemental Disclosure of Non-Cash Investing and Financing Activities          
Reduction of derivative liabilities  2.12.93.24.63.02.31.9 
Issuance of shares--common stock payable   1.5  0.9   
Issuance of common stock for conversion of debt  2.53.64.85.34.52.91.7 
Discount on derivative liability upon issuance of debt   0.32.31.91.81.41.1 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy